Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.
Kivivuori
Sanna-Maria
SM
Children’s Hospital, Helsinki University Central Hospital, University of Helsinki, Finland. sanna.kivivuori@iki.fi
Riikonen
Pekka
P
Valanne
Leena
L
Lönnqvist
Tuula
T
Saarinen-Pihkala
Ulla M
UM
D000293:Adolescent; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D020295:Brain Stem Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D000068579:Celecoxib; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005047:Etoposide / Q000008:administration & dosage; D005910:Glioma / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D010865:Pilot Projects; D011720:Pyrazoles / Q000008:administration & dosage; D011788:Quality of Life; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage; D016019:Survival Analysis; D013792:Thalidomide / Q000008:administration & dosage; D019772:Topotecan / Q000627:therapeutic use*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D011720:Pyrazoles; D011838:Radiation-Sensitizing Agents; D013449:Sulfonamides; D013792:Thalidomide; D005047:Etoposide; D019772:Topotecan; D000068579:Celecoxib